Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update Aug 10, 2023 04:34PM
Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis Aug 8, 2023 08:30AM
Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb® in Ten U.S. Hotspot States under Emergency Use Authorization for COVID-19 Aug 24, 2020 07:00AM